Article Information
History
- November 9, 2023.
Article Versions
- Version 1 (October 2, 2023 - 09:04).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Pankaj J. Pasricha1,*,
- Megan McKnight2,
- Luisa Villatoro1,
- Guillermo Barahona1,
- Jeffrey Brinker2,
- Ken Hui2,
- Michael Polydefkis1,
- Robert Burns2,
- Zsuzsanna H. McMahan3,
- Neda Gould2,
- Brent Goodman1,
- Joseph Hentz1 and
- Glenn Treisman2
- 1Mayo Clinic, Scottsdale, AZ, USA
- 2Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 3Univeristy of Texas Health Science Center, Houston, TX, USA
- ↵*Correspondence: Pankaj Jay Pasricha MBBS MD Chair, Department of Medicine at Mayo Clinic in Arizona, Scottsdale, AZ, United States. Email: Pasricha.Jay{at}mayo.edu
Posted November 09, 2023.
A Syndrome of Joint Hypermobility, Autonomic Dysfunction, Gastrointestinal Dysfunction and Autoimmune markers (JAG-A): Clinical Associations and Response to Intravenous Immunoglobulin Therapy
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos